Moderna Inc at Sanford C Bernstein Operational Decisions Conference Transcript
Hi, everybody, and thank you for joining us in the end of earnings day to actually participate in this conference call with Stephane Bancel, the CEO of Moderna. We'll try to cover 4 topics today a little bit by the logic of durability of the business of COVID-19 vaccines, the challenge of multivalent vaccines, curing additional diseases beyond immunogenicity, and a little bit about the experience of being a CEO of the company that attempts to change the world by -- while growing up at the same time. So Stephane, thank you very much for joining us today.
Thank you for having me.
Questions & Answers
So let's start with a discussion of the logic of boosting long term. So I think at this point, we kind of realize there is a logic to boost people once after getting the 2 initial shots. The question is the logic and evidence for the need for boosting every year.
There seems to be some debate that we will be building
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |